Abstract
Objectives: Neuroleptic Malignant Syndrome (NMS) is a potentially life threatening condition, uncommon in children, characterized by hyperthermia, muscle rigidity, elevated creatine kinase (CK) levels, and autonomic instability. It is often precipitated by use of high dose neuroleptics. The purpose of this study is to raise awareness of the course and prognosis of NMS in a pediatric population to optimize strategies for early diagnosis and effective interventions.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
